AngioDynamics, Inc. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
AngioDynamics, Inc. (ANGO) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $267.00 thousand for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-07-14
- AngioDynamics, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-08-31 was $191.00K, a 64.66% increase year-over-year.
- AngioDynamics, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-08-31 was $116.00K, a 792.31% increase year-over-year.
- AngioDynamics, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-08-31 was $13.00K.
- AngioDynamics, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2022-08-31 was -$316.00K.
- AngioDynamics, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2026 was $267.00K, a 32.91% decline from fiscal 2025.
- AngioDynamics, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $398.00K, a 218.40% increase from fiscal 2024.
- AngioDynamics, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was $125.00K, a 190.70% increase from fiscal 2023.
- AngioDynamics, Inc. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $43.00K.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-05-31 | $267.00K 10-K · filed 2026-07-14 | |||
| 2026-02-28 | $287.00K 10-Q · filed 2026-04-02 | |||
| 2025-11-30 | $119.00K 10-Q · filed 2026-01-06 | |||
| 2025-08-31 | $191.00K 10-Q · filed 2025-10-02 | |||
| 2025-05-31 | $398.00K 10-K · filed 2026-07-14 | |||
| 2025-02-28 | -$317.00K 10-Q · filed 2026-04-02 | |||
| 2024-11-30 | -$189.00K 10-Q · filed 2026-01-06 | |||
| 2024-08-31 | $116.00K 10-Q · filed 2025-10-02 | |||
| 2024-05-31 | $125.00K 10-K · filed 2026-07-14 | |||
| 2024-02-29 | $185.00K 10-Q · filed 2025-04-02 | |||
| 2023-11-30 | $202.00K 10-Q · filed 2025-01-08 | |||
| 2023-08-31 | $13.00K 10-Q · filed 2024-10-03 | |||
| 2023-05-31 | $43.00K 10-K · filed 2025-07-18 | |||
| 2023-02-28 | -$40.00K 10-Q · filed 2024-04-09 | |||
| 2022-11-30 | -$129.00K 10-Q · filed 2024-01-08 | |||
| 2022-08-31 | -$316.00K 10-Q · filed 2023-10-05 | |||
| 2022-05-31 | -$518.00K 10-K · filed 2024-07-25 | |||
| 2022-02-28 | -$337.00K 10-Q · filed 2023-03-31 | |||
| 2021-11-30 | -$354.00K 10-Q · filed 2023-01-06 | |||
| 2021-08-31 | -$139.00K 10-Q · filed 2022-10-11 | |||
| 2021-05-31 | $330.00K 10-K · filed 2023-08-03 | |||
| 2021-02-28 | $248.00K 10-Q · filed 2022-04-07 | |||
| 2020-05-31 | -$65.00K 10-K · filed 2022-07-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |